Dr. Reddy's Laboratories Limited Stock Analysis & AI Score
Dr. Reddy's Laboratories Limited (RDY) has an ST Score of 43.8 (C), driven by its Profitability (A) and held back by its Sentiment (F). Analysts rate it Buy.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NYSE |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Dr. Reddy's Laboratories Limited (RDY) has an ST Score of 43.8 (C), driven by its Profitability (A) and held back by its Sentiment (F). Analysts rate it Buy.
- Strongest
- ProfitabilityA
- Weakest
- SentimentF
All factor grades
- ProfitabilityA
- Financial StrengthB
- MomentumC+
- GrowthC-
- ValuationD+
- SentimentF
- Piotroski5/9
Contact
RDY stock: frequently asked questions
What is RDY's ST Score?
Dr. Reddy's Laboratories Limited (RDY) has an ST Score of 43.8 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is RDY a buy, hold, or sell?
Analysts rate RDY a Buy. Our ST Score grades it C (43.8/100). The ST Score is a data-driven signal, not a recommendation.
What are RDY's factor grades?
Valuation D+, Profitability A, Financial Strength B, Momentum C+, Growth C-, Sentiment F.
What is RDY's valuation grade?
Dr. Reddy's Laboratories Limited (RDY) earns a valuation grade of D+, measured against Drug Manufacturers - Specialty & Generic peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is RDY's growth grade?
Dr. Reddy's Laboratories Limited (RDY) earns a growth grade of C-, measured against Drug Manufacturers - Specialty & Generic peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is RDY's profitability grade?
Dr. Reddy's Laboratories Limited (RDY) earns a profitability grade of A, measured against Drug Manufacturers - Specialty & Generic peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is RDY's financial strength grade?
Dr. Reddy's Laboratories Limited (RDY) earns a financial strength grade of B, measured against Drug Manufacturers - Specialty & Generic peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is RDY's Piotroski score?
Dr. Reddy's Laboratories Limited (RDY) has a Piotroski F-Score of 5 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.